1. Home
  2. ACH vs RCEL Comparison

ACH vs RCEL Comparison

Compare ACH & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACH

Accendra Health Inc.

N/A

Current Price

$3.10

Market Cap

173.3M

Sector

N/A

ML Signal

N/A

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$4.55

Market Cap

171.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACH
RCEL
Founded
1882
N/A
Country
United States
United States
Employees
N/A
226
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
173.3M
171.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ACH
RCEL
Price
$3.10
$4.55
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$3.38
$7.88
AVG Volume (30 Days)
880.2K
177.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
$4.43
$49.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$3.22
52 Week High
$4.69
$7.12

Technical Indicators

Market Signals
Indicator
ACH
RCEL
Relative Strength Index (RSI) 43.78 53.98
Support Level $1.99 $4.09
Resistance Level $3.99 $5.85
Average True Range (ATR) 0.42 0.33
MACD -0.12 0.00
Stochastic Oscillator 8.57 35.44

Price Performance

Historical Comparison
ACH
RCEL

About ACH Accendra Health Inc.

Accendra Health Inc is a world-wide healthcare solutions company providing essential products, services and technology solutions that support care delivery in hospitals, health systems and research centers around the world.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: